November   Amoxicillin capsules passed the quality consistency evaluation for generic drugs.

November   Dihydroartemisinin / Piperaquine phosphate Tablets passed the WHO-PQ certification.

April    Artesunate for injection become the first-line drug for the treatment of severe malaria in the United States.

October    Sulfadoxine/pyrimethamine tablets passed WHO drug pre-certification.

August    SPAQ-CO Dispersible Tablets passed WHO drug pre-certification.

August    The injection manufacturing center accepted the WHO re-inspection and successfully passed the GMP on-site audit.

September    A total of 7 production lines of APIs, oral preparations and injections in the Qilidian factory passed the WHO-GMP on-site audit.

March    Bumetanide raw materials (Qilidian plant) passed the US FDA certification.

Jannuary    The company’s star product, artesunate for injection, was selected into the annual 'Honor List' of French independent medical journal PRESCRIRE.

October    Artesunate-Amodiaquine Tablets passed WHO-PQ certification.

July    The company accepted WHO routine GMP audit.

March    Powder injections and small-volume injections passed the GMP certification of the State Food and Drug Administration.

November    Artesunate-Amodiaquine Tablets(double-layer tablets) passed the WHO-PQ certification.

May    Artesunate +  Sulfadoxine/ Pyrimethamine co-blistered tablets passed WHO-PQ certificatopn.

November    Artesunate for injection passed WHO-PQ certification.

August    Artesunate tablets/amodiaquine hydrochloride tablets combined medication and amodiaquine hydrochloride tablets passed WHO-PQ certification.

December    Artesunate tablets passed WHO drug pre-certification.